- Ursodeoxycholic acid shows antineoplastic effects in bile duct cancer cells via apoptosis induction; p53 activation; and EGFR-ERK, COX-2, and PI3K-AKT pathway inhibition
Jin Lee et al, 2021, Molecular Biology Reports CrossRef - Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells
Tzu-En Huang et al, 2020, Frontiers in Pharmacology CrossRef - Chenodeoxycholic Acid Enhances the Effect of Sorafenib in Inhibiting HepG2 Cell Growth Through EGFR/Stat3 Pathway
Yang Zhang et al, 2022, Frontiers in Oncology CrossRef - Berbamine (BBM), a Natural STAT3 Inhibitor, Synergistically Enhances the Antigrowth and Proapoptotic Effects of Sorafenib on Hepatocellular Carcinoma Cells
Weijia Zhao et al, 2020, ACS Omega CrossRef - The anticancer activity of bile acids in drug discovery and development
Weijian Li et al, 2024, Frontiers in Pharmacology CrossRef